March 29, 2011 -- Merck plans to increase its China sales over the next two years to the point where they contribute 25% of the company’s overall revenues, according to Merck’s new CEO, Kenneth Frazier. The company was the fastest growing of any multinational pharma during Q4 in China in terms of the number of units sold, Frazier said. More details....
Stock Symbol: (NYSE: MRK)
